Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines — a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261–79. https://doi.org/10.1038/nrd.2017.243.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 2021;20(11):817–38. https://doi.org/10.1038/s41573-021-00283-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hassett KJ, Benenato KE, Jacquinet E, Lee A, Woods A, Yuzhakov O, Himansu S, Deterling J, Geilich BM, Ketova T, et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol Ther - Nucleic Acids. 2019;15:1–11. https://doi.org/10.1016/j.omtn.2019.01.013.

Article  PubMed  PubMed Central  CAS  Google Scholar 

McKay PF, Hu K, Blakney AK, Samnuan K, Brown JC, Penn R, Zhou J, Bouton CR, Rogers P, Polra K, et al. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nat Commun. 2020;11(1):3523. https://doi.org/10.1038/s41467-020-17409-9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Alameh M-G, Tombácz I, Bettini E, Lederer K, Sittplangkoon C, Wilmore JR, Gaudette BT, Soliman OY, Pine M, Hicks P, et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity. 2022;55(6):1136–8. https://doi.org/10.1016/j.immuni.2022.05.007.

Article  PubMed  PubMed Central  Google Scholar 

Beck JD, Reidenbach D, Salomon N, Sahin U, Türeci Ö, Vormehr M, Kranz LM. mRNA therapeutics in cancer immunotherapy. Mol Cancer. 2021;20(1):69. https://doi.org/10.1186/s12943-021-01348-0

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu C, Shi Q, Huang X, Koo S, Kong N, Tao W. mRNA-based cancer therapeutics. Nat Rev Cancer. 2023;23(8):526–43. https://doi.org/10.1038/s41568-023-00586-2.

Article  PubMed  CAS  Google Scholar 

Miao L, Li L, Huang Y, Delcassian D, Chahal J, Han J, Shi Y, Sadtler K, Gao W, Lin J, et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat Biotechnol. 2019;37(10):1174–85. https://doi.org/10.1038/s41587-019-0247-3.

Article  PubMed  CAS  Google Scholar 

Sahin U, Oehm P, Derhovanessian E, Jabulowsky RA, Vormehr M, Gold M, Maurus D, Schwarck-Kokarakis D, Kuhn AN, Omokoko T, et al. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature. 2020;585(7823):107–12. https://doi.org/10.1038/s41586-020-2537-9.

Article  PubMed  CAS  Google Scholar 

Zhang H, You X, Wang X, Cui L, Wang Z, Xu F, Li M, Yang Z, Liu J, Huang P, et al. Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling. Proc Natl Acad Sci. 2021;118(6):e2005191118. https://doi.org/10.1073/pnas.2005191118.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sahu I, Haque AKMA, Weidensee B, Weinmann P, Kormann MSD. Recent developments in mRNA-Based protein supplementation therapy to target lung diseases. Mol Ther. 2019;27(4):803–23. https://doi.org/10.1016/j.ymthe.2019.02.019.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vavilis T, Stamoula E, Ainatzoglou A, Sachinidis A, Lamprinou M, Dardalas I, Vizirianakis. IS. mRNA in the context of protein replacement therapy. Pharmaceutics. 2023;15(1):166. https://doi.org/10.3390/pharmaceutics15010166

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li B, Luo X, Deng B, Wang J, McComb DW, Shi Y, Gaensler KML, Tan X, Dunn AL, Kerlin BA, et al. An orthogonal array optimization of Lipid-like nanoparticles for mRNA delivery in vivo. Nano Lett. 2015;15(12):8099–107. https://doi.org/10.1021/acs.nanolett.5b03528.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Robinson E, MacDonald KD, Slaughter K, McKinney M, Patel S, Sun C, Sahay G. Lipid Nanoparticle-Delivered chemically modified mRNA restores chloride secretion in cystic fibrosis. Mol Ther. 2018;26(8):2034–46. https://doi.org/10.1016/j.ymthe.2018.05.014.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Veiga N, Goldsmith M, Granot Y, Rosenblum D, Dammes N, Kedmi R, Ramishetti S, Peer D. Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nat Commun. 2018;9(1):1–9. https://doi.org/10.1038/s41467-018-06936-1.

Article  CAS  Google Scholar 

Popovitz J, Sharma R, Hoshyar R, Soo Kim B, Murthy N, Lee K. Gene editing therapeutics based on mRNA delivery. Adv Drug Deliv Rev. 2023;200:115026. https://doi.org/10.1016/j.addr.2023.115026.

Article  PubMed  CAS  Google Scholar 

Li W, Wang C, Lu Y. When mRNA Meets gene editing. Nano Res. 2024;17(8):7337–56. https://doi.org/10.1007/s12274-024-6729-8.

Article  CAS  Google Scholar 

Sun YH, Chatterjee S, Lian XZ, Traylor Z, Sattiraju SR, Xiao YF, Dilliard SA, Sung YC, Kim M, Lee SM, et al. In vivo editing of lung stem cells for durable gene correction in mice. Science. 2024;384(6701):1196–202. https://doi.org/10.1126/science.adk9428.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li B, Manan RS, Liang S-Q, Gordon A, Jiang A, Varley A, Gao G, Langer R, Xue W, Anderson D. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat Biotechnol. 2023;41(10):1410–5. https://doi.org/10.1038/s41587-023-01679-x.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Qiu M, Glass Z, Chen J, Haas M, Jin X, Zhao X, Rui X, Ye Z, Li Y, Zhang F, et al. Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing ofAngptl3. Proc Natl Acad Sci. 2021;118(10):e2020401118. https://doi.org/10.1073/pnas.2020401118.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang T, Upponi JR, Torchilin VP. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. Int J Pharm. 2012;427(1):3–20. https://doi.org/10.1016/j.ijpharm.2011.07.013.

Article  PubMed  CAS  Google Scholar 

Sahay G, Querbes W, Alabi C, Eltoukhy A, Sarkar S, Zurenko C, Karagiannis E, Love K, Chen D, Zoncu R, et al. Efficiency of SiRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol. 2013;31(7):653–8. https://doi.org/10.1038/nbt.2614.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014;15(8):541–55. https://doi.org/10.1038/nrg3763.

Article  PubMed  CAS  Google Scholar 

Sorrentino S. Human extracellular ribonucleases: multiplicity, molecular diversity and catalytic properties of the major RNase types. Cell Mol Life Sci. 1998;54(8):785–94.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sean C, Semple AC, Pieter R, Cullis. Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo. Adv Drug Deliv Rev. 1998;32(1,2):3–17.

Google Scholar 

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078–94. https://doi.org/10.1038/s41578-021-00358-0.

Article  PubMed